CS
COV

Credit Suisse’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Credit Suisse’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,347,064
Closed -$240M – 4829
2014
Q4 		$240M Sell
2,347,064
-231,790
-9% -$22.2M 0.21% 93
2014
Q3 		$223M Buy
2,578,854
+892,973
+53% +$79.1M 0.18% 101
2014
Q2 		$152M Buy
1,685,881
+836,986
+99% +$62.6M 0.12% 158
2014
Q1 		$62.5M Sell
848,895
-10,292
-1% -$718K 0.06% 333
2013
Q4 		$58.5M Buy
859,187
+118,642
+16% +$7.72M 0.05% 356
2013
Q3 		$45.1M Sell
740,545
-325,866
-31% -$19.9M 0.04% 384
2013
Q2 		$59.4M Buy
+1,066,411
New +$61.7M 0.06% 322

Credit Suisse's COV Position: Q1 2015 in Review

Credit Suisse sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,347,064 shares — an estimated $240M sold.

Credit Suisse first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $240M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Credit Suisse reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Credit Suisse sold 2,347,064 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $240M.
  • Credit Suisse first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Credit Suisse's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $240M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.